Release Date: 07/06/11 15:54 Summary: Change of Director's Interest Notice - Reilly Price Sensitive: No Download Document 28.61KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling